Comparison of glatiramer acetate (Copaxone®) and interferon β-1b (Betaferon®) in multiple sclerosis patients: an open-label 2-year follow-up

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

1983 • 7,404 citations

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

1996 • 2,410 citations

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1998 • 2,049 citations

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

1995 • 1,903 citations

A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis

1987 • 465 citations

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

1971 • 431 citations

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis

1995 • 230 citations

Management of Multiple Sclerosis

1997 • 202 citations

Management of patients receiving interferon beta-1b for multiple sclerosis

1996 • 171 citations

Handbook of Multiple Sclerosis

1991 • 168 citations

Copolymer 1: from basic research to clinical application

1997 • 73 citations

Interferons in the Treatment of Multiple Sclerosis

1998 • 51 citations

Safety profile of copolymer 1: Analysis of cumulative experience in the United States and Israel

1996 • 36 citations

Practice advisory on selection of patients with multiple sclerosis for treatment with Betaseron [RETIRED]

1994 • 30 citations

Frontiers in Multiple Sclerosis: Clinical Research and Therapy

1997 • 21 citations

Frontiers in multiple sclerosis : clinical research and therapy

1997 • 21 citations

Suppression of experimental allergic encephalomyelitis by COP1--relevance to multiple sclerosis.

1989 • 18 citations

Therapeutic advances: beta-interferon for multiple sclerosis

1996 • 9 citations